Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rhinitis | 17 | 2023 | 691 | 3.530 |
Why?
|
Sinusitis | 18 | 2023 | 923 | 3.230 |
Why?
|
Endoscopy | 17 | 2023 | 1787 | 2.560 |
Why?
|
Nasal Polyps | 7 | 2023 | 360 | 2.190 |
Why?
|
Paranasal Sinuses | 7 | 2021 | 250 | 2.130 |
Why?
|
Turbinates | 2 | 2019 | 68 | 1.220 |
Why?
|
Decision Trees | 5 | 2020 | 506 | 1.030 |
Why?
|
Skull Base | 3 | 2017 | 306 | 0.950 |
Why?
|
Cost-Benefit Analysis | 8 | 2021 | 5388 | 0.810 |
Why?
|
Natural Orifice Endoscopic Surgery | 2 | 2019 | 118 | 0.750 |
Why?
|
Cautery | 1 | 2020 | 72 | 0.730 |
Why?
|
Suction | 1 | 2020 | 267 | 0.680 |
Why?
|
Paranasal Sinus Diseases | 1 | 2020 | 116 | 0.670 |
Why?
|
Skull Base Neoplasms | 2 | 2024 | 284 | 0.620 |
Why?
|
Nasopharynx | 1 | 2020 | 379 | 0.610 |
Why?
|
Frontal Sinus | 1 | 2017 | 50 | 0.600 |
Why?
|
Drug-Eluting Stents | 2 | 2020 | 753 | 0.550 |
Why?
|
Rhinoplasty | 1 | 2019 | 226 | 0.520 |
Why?
|
Dacryocystorhinostomy | 3 | 2020 | 72 | 0.510 |
Why?
|
Smell | 1 | 2017 | 244 | 0.500 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2017 | 234 | 0.500 |
Why?
|
Olfaction Disorders | 1 | 2017 | 222 | 0.480 |
Why?
|
Outpatients | 1 | 2021 | 1487 | 0.460 |
Why?
|
Chronic Disease | 14 | 2023 | 9145 | 0.450 |
Why?
|
Mucocele | 1 | 2013 | 49 | 0.450 |
Why?
|
Otolaryngology | 4 | 2022 | 645 | 0.450 |
Why?
|
Quality-Adjusted Life Years | 6 | 2020 | 1683 | 0.430 |
Why?
|
Quality of Life | 8 | 2023 | 12802 | 0.420 |
Why?
|
Adrenal Cortex Hormones | 2 | 2022 | 1856 | 0.410 |
Why?
|
Markov Chains | 4 | 2021 | 969 | 0.370 |
Why?
|
Models, Economic | 4 | 2021 | 712 | 0.350 |
Why?
|
MEDLINE | 1 | 2008 | 125 | 0.320 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2017 | 3480 | 0.320 |
Why?
|
Medicare | 5 | 2022 | 6566 | 0.320 |
Why?
|
Ambulatory Care | 2 | 2015 | 2708 | 0.290 |
Why?
|
Pituitary Neoplasms | 1 | 2014 | 1345 | 0.270 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2008 | 300 | 0.250 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 2 | 2020 | 312 | 0.240 |
Why?
|
Nasolacrimal Duct | 2 | 2020 | 74 | 0.220 |
Why?
|
Biological Products | 2 | 2022 | 860 | 0.220 |
Why?
|
Lacrimal Duct Obstruction | 2 | 2019 | 48 | 0.210 |
Why?
|
Cadaver | 3 | 2020 | 1337 | 0.210 |
Why?
|
Tampons, Surgical | 1 | 2021 | 10 | 0.200 |
Why?
|
Aerosols | 2 | 2020 | 625 | 0.190 |
Why?
|
Dilatation | 2 | 2020 | 291 | 0.190 |
Why?
|
Nose | 2 | 2024 | 509 | 0.190 |
Why?
|
Epistaxis | 1 | 2021 | 111 | 0.180 |
Why?
|
Dacryocystitis | 1 | 2020 | 70 | 0.180 |
Why?
|
Nose Diseases | 1 | 2020 | 79 | 0.180 |
Why?
|
Meningioma | 2 | 2024 | 1209 | 0.170 |
Why?
|
Humans | 46 | 2024 | 744366 | 0.160 |
Why?
|
Emergency Service, Hospital | 2 | 2015 | 7658 | 0.160 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2019 | 65 | 0.160 |
Why?
|
Reoperation | 2 | 2019 | 4201 | 0.160 |
Why?
|
Asthma | 1 | 2017 | 6010 | 0.160 |
Why?
|
Health Services Accessibility | 2 | 2015 | 5135 | 0.160 |
Why?
|
Off-Label Use | 1 | 2019 | 169 | 0.150 |
Why?
|
Rhinometry, Acoustic | 1 | 2017 | 8 | 0.150 |
Why?
|
Device Approval | 1 | 2019 | 163 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.150 |
Why?
|
Eye Neoplasms | 1 | 2019 | 312 | 0.150 |
Why?
|
Granuloma | 1 | 2019 | 319 | 0.140 |
Why?
|
Equipment and Supplies | 1 | 2019 | 281 | 0.140 |
Why?
|
Cost Savings | 1 | 2021 | 925 | 0.140 |
Why?
|
Internet | 1 | 2008 | 3056 | 0.140 |
Why?
|
Antibiotic Prophylaxis | 1 | 2021 | 639 | 0.130 |
Why?
|
Larynx, Artificial | 1 | 2015 | 69 | 0.130 |
Why?
|
Treatment Outcome | 12 | 2024 | 63107 | 0.130 |
Why?
|
Nasal Mucosa | 1 | 2017 | 373 | 0.130 |
Why?
|
Pneumonia, Aspiration | 1 | 2015 | 145 | 0.130 |
Why?
|
Meningeal Neoplasms | 1 | 2024 | 1241 | 0.120 |
Why?
|
Shock, Septic | 1 | 2021 | 775 | 0.120 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1680 | 0.120 |
Why?
|
Clostridium Infections | 1 | 2021 | 548 | 0.120 |
Why?
|
Laryngectomy | 1 | 2015 | 248 | 0.120 |
Why?
|
Craniotomy | 1 | 2017 | 729 | 0.110 |
Why?
|
United States | 12 | 2023 | 69872 | 0.110 |
Why?
|
Conflict of Interest | 1 | 2018 | 544 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 2019 | 1602 | 0.110 |
Why?
|
Hypersensitivity | 1 | 2021 | 1102 | 0.110 |
Why?
|
Hypopituitarism | 1 | 2014 | 254 | 0.110 |
Why?
|
Voice | 1 | 2015 | 259 | 0.100 |
Why?
|
Postoperative Care | 1 | 2019 | 1487 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3135 | 0.100 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 25039 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3242 | 0.100 |
Why?
|
Prospective Studies | 7 | 2023 | 53290 | 0.100 |
Why?
|
Fixatives | 1 | 2010 | 94 | 0.100 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2010 | 126 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2021 | 1956 | 0.090 |
Why?
|
Acute Disease | 3 | 2015 | 7147 | 0.090 |
Why?
|
Prosthesis-Related Infections | 1 | 2015 | 538 | 0.090 |
Why?
|
Trachea | 1 | 2015 | 1076 | 0.090 |
Why?
|
Esophagus | 1 | 2015 | 1019 | 0.090 |
Why?
|
Paraffin Embedding | 1 | 2010 | 299 | 0.090 |
Why?
|
Health Status Indicators | 1 | 2014 | 970 | 0.080 |
Why?
|
Formaldehyde | 1 | 2010 | 353 | 0.080 |
Why?
|
Postoperative Complications | 5 | 2019 | 15297 | 0.080 |
Why?
|
Surgical Flaps | 1 | 2017 | 1640 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1790 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2015 | 2110 | 0.080 |
Why?
|
Male | 16 | 2023 | 350115 | 0.080 |
Why?
|
Particulate Matter | 1 | 2020 | 2529 | 0.080 |
Why?
|
Female | 17 | 2023 | 380193 | 0.080 |
Why?
|
Absorbable Implants | 2 | 2022 | 342 | 0.080 |
Why?
|
Middle Aged | 10 | 2021 | 213390 | 0.080 |
Why?
|
Adult | 10 | 2020 | 214052 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3611 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2460 | 0.070 |
Why?
|
Headache | 1 | 2013 | 1226 | 0.060 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 477 | 0.060 |
Why?
|
Health Status | 1 | 2018 | 4034 | 0.060 |
Why?
|
Retrospective Studies | 9 | 2024 | 77460 | 0.060 |
Why?
|
Aged | 9 | 2022 | 163288 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4567 | 0.060 |
Why?
|
Nasal Lavage | 1 | 2023 | 11 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2015 | 1900 | 0.060 |
Why?
|
BRCA1 Protein | 1 | 2009 | 1149 | 0.050 |
Why?
|
Chromosome Aberrations | 1 | 2009 | 1813 | 0.050 |
Why?
|
Insurance, Health | 1 | 2015 | 2494 | 0.050 |
Why?
|
Budesonide | 1 | 2023 | 154 | 0.050 |
Why?
|
Nasal Cavity | 1 | 2024 | 313 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18373 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12961 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 40559 | 0.050 |
Why?
|
Sneezing | 1 | 2020 | 17 | 0.050 |
Why?
|
Uterine Neoplasms | 1 | 2009 | 1513 | 0.050 |
Why?
|
Information Dissemination | 1 | 2008 | 1099 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15535 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 779 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2019 | 520 | 0.040 |
Why?
|
Tissue Adhesions | 1 | 2019 | 235 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2008 | 5974 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12244 | 0.040 |
Why?
|
Steroids | 1 | 2022 | 930 | 0.040 |
Why?
|
Nasal Obstruction | 1 | 2019 | 151 | 0.040 |
Why?
|
Resource Allocation | 1 | 2018 | 341 | 0.030 |
Why?
|
Granulation Tissue | 1 | 2015 | 93 | 0.030 |
Why?
|
Health Expenditures | 2 | 2022 | 2349 | 0.030 |
Why?
|
Particle Size | 1 | 2020 | 1642 | 0.030 |
Why?
|
Prosthesis Fitting | 1 | 2015 | 74 | 0.030 |
Why?
|
Glioma | 1 | 2010 | 3401 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2023 | 1584 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39052 | 0.030 |
Why?
|
Sheep | 1 | 2017 | 1437 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3841 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2018 | 57776 | 0.030 |
Why?
|
Punctures | 1 | 2015 | 374 | 0.030 |
Why?
|
Voice Quality | 1 | 2015 | 217 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 3922 | 0.030 |
Why?
|
Laryngeal Neoplasms | 1 | 2015 | 512 | 0.030 |
Why?
|
Medicaid | 2 | 2015 | 2737 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2018 | 1011 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12262 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 7785 | 0.020 |
Why?
|
Young Adult | 2 | 2018 | 56429 | 0.020 |
Why?
|
Skilled Nursing Facilities | 1 | 2015 | 372 | 0.020 |
Why?
|
Office Visits | 1 | 2015 | 598 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 642 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2015 | 1206 | 0.020 |
Why?
|
Frozen Sections | 1 | 2010 | 155 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8385 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2010 | 496 | 0.020 |
Why?
|
Oligodendroglioma | 1 | 2010 | 279 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2009 | 8861 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2015 | 1049 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2015 | 2453 | 0.020 |
Why?
|
Anti-Mullerian Hormone | 1 | 2009 | 402 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2540 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2009 | 658 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6755 | 0.020 |
Why?
|
Integrases | 1 | 2009 | 533 | 0.020 |
Why?
|
Wound Healing | 1 | 2017 | 2785 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2009 | 1799 | 0.020 |
Why?
|
Income | 1 | 2015 | 1913 | 0.020 |
Why?
|
Quality Control | 1 | 2008 | 841 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2014 | 2419 | 0.020 |
Why?
|
Health Care Costs | 1 | 2019 | 3208 | 0.020 |
Why?
|
Gene Dosage | 1 | 2009 | 1252 | 0.020 |
Why?
|
Odds Ratio | 1 | 2015 | 9849 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2014 | 3395 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20952 | 0.010 |
Why?
|
Down-Regulation | 1 | 2009 | 3001 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 1837 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19905 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2015 | 3154 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2009 | 2949 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18034 | 0.010 |
Why?
|
Primary Health Care | 1 | 2015 | 4557 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5867 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2716 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9735 | 0.010 |
Why?
|
Computational Biology | 1 | 2008 | 3519 | 0.010 |
Why?
|
DNA Methylation | 1 | 2009 | 4285 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14723 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2008 | 2213 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14561 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 16690 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9445 | 0.010 |
Why?
|
Models, Statistical | 1 | 2008 | 5101 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72296 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40075 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13286 | 0.010 |
Why?
|
Animals | 2 | 2017 | 168768 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 85779 | 0.010 |
Why?
|
Prognosis | 1 | 2009 | 29060 | 0.010 |
Why?
|
Algorithms | 1 | 2008 | 13882 | 0.000 |
Why?
|
Child | 1 | 2015 | 77709 | 0.000 |
Why?
|
Mice | 1 | 2009 | 81201 | 0.000 |
Why?
|
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(38)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_